CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Clinical trials for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA explained in plain language.
Never miss a new study
Get alerted when new CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA trials appear
Sign up with your email to follow new studies for CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug tested for rare, dangerous heart rhythm disorder
Disease control Recruiting nowThis study is testing an investigational drug called CRD-4730 in adults diagnosed with CPVT, a genetic condition that causes dangerous, fast heart rhythms during exercise or stress. The main goals are to see if the drug is safe, how the body processes it, and if it can reduce irr…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
First human test of gene therapy for deadly heart rhythm disorder
Disease control Recruiting nowThis is an early safety study testing a single dose of an experimental gene therapy called SGT-501 in people with CPVT, a rare inherited condition that causes dangerous fast heart rhythms during exercise or stress. The main goal is to see if the treatment is safe and tolerable in…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE1 • Sponsor: Solid Biosciences Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill aims to tame deadly Stress-Induced heart condition
Disease control Recruiting nowThis study is testing a new oral drug called AGP100 for people with a serious inherited heart condition called CPVT. CPVT causes the heart to beat dangerously fast during physical or emotional stress, even with current medications. The trial will check if AGP100 is safe and if it…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Phase: PHASE2 • Sponsor: Agiana Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Brazil launches national gene hunt for heart disease families
Knowledge-focused Recruiting nowThis study aims to create a national registry of Brazilian patients with inherited heart conditions to understand which genes are involved and how common different genetic changes are in the population. Researchers will collect medical information and DNA samples from 600 partici…
Matched conditions: CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Sponsor: Hospital do Coracao • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC